1. Huntingtin protein: A new option for fixing the Huntington's disease countdown clock
   Marco Caterino et al, 2018, Neuropharmacology CrossRef
2. Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models
   Laurent Coudert et al, 2019, Cell. Mol. Life Sci. CrossRef
3. Protein Misfolding and ER Stress in Huntington's Disease
   Talya Shacham et al, 2019, Front. Mol. Biosci. CrossRef
4. Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration
   Carla Ribeiro Alvares Batista et al, 2019, IJMS CrossRef
5. Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review
   Larissa-Nele Schaffert et al, 2020, Brain Sciences CrossRef
6. Bioinformatic analysis of microRNA expression in Huntington's disease
   Xiaoyu Dong et al, 2018, Mol Med Report CrossRef
7. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach
   Dia Advani et al, 2020, Neurochemistry International CrossRef
8. Stem cell in neurodegenerative disorders; an emerging strategy
   Milad Ahani‐Nahayati et al, 2021, Int. j. dev. neurosci. CrossRef
9. Cannabinoids as anticancer and neuroprotective drugs: Structural insights and pharmacological interactions—A review
   Arivalagan Pugazhendhi et al, 2021, Process Biochemistry CrossRef
10. Zebrafish an experimental model of Huntington’s disease: molecular aspects, therapeutic targets and current challenges
    Vishal Kumar et al, 2021, Mol Biol Rep CrossRef
11. Protective Effects of Polysaccharides in Neurodegenerative Diseases
    Yinying Wang et al, 2022, Front. Aging Neurosci. CrossRef
12. Computational insights into missense mutations in HTT gene causing Huntington’s disease and its interactome networks
    Muneeza Qayyum Khan et al, 2022, Ir J Med Sci CrossRef
13. Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects
    Mohaddeseh Rahbaran et al, 2022, Cell Mol Biol Lett CrossRef
14. The Brain Protein Atlas: A conglomerate of proteomics datasets of human neural tissue
    K.H. Brian Lam et al, 2022, Proteomics CrossRef
15. Neuroprotective Effects of Black Pepper and Its Bioactive Compounds in Age-Related Neurological Disorders
    Rengasamy Balakrishnan et al, 2022, Aging and disease CrossRef
16. CRISPR/Cas9 Mediated Therapeutic Approach in Huntington’s Disease
    Suleyman Serdar Alkanli et al, 2022, Mol Neurobiol CrossRef
17. null
    Reihaneh Seyedebrahimi et al, 2024 CrossRef
18. Aptamer Applications in Neuroscience.
    Meric Ozturk et al, 2021, Pharmaceuticals (Basel) CrossRef
19. Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease
    Amelie Marie Back et al, 2024, J of Neuroscience Research CrossRef
20. The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: A narrative review
    Abdullahi Tunde Aborode et al, 2025, NeuroMarkers CrossRef